Skip to main content
Paul McCrone

Professor Paul McCrone

Professor of Healthcare Economics

Biography

Professor Paul McCrone is based within the Institute for Lifecourse Development at the University of Greenwich and is responsible for leading health economics research. Paul is an economist by background and studied for his undergraduate degree at (the then) Thames Polytechnic in Woolwich. He has specialised in health economics since 1990 and has been involved in a large number of economic studies across many different healthcare areas.

News

£1.3 million Wellcome funding awarded to SlowMo

SlowMo, an inclusive, digitally supported therapy for paranoia, has been awarded £1.3 million funding by Wellcome to scale up in three NHS Trusts.

Person is shown holding a mobile phone with the SlowMo app open. Another person is shown walking past them. The top of the screen displays the text "Hi Angela, what are you thinking about?'. In the middle of the screen, a worry bubble is shown which has the text 'Someone is following me'. The bottom of the screen says 'What is you thought? Tap the bubble to enter your thought or swipe to see previous thoughts'

Optimising immunosuppression based on antibody testing does little to reduce kidney transplant failure rate

Treating patients who possess transplant rejecting antibodies, using best available combinations of oral drugs, does not have an impact on transplant failure...

Dialysis

News

£1.3 million Wellcome funding awarded to SlowMo

SlowMo, an inclusive, digitally supported therapy for paranoia, has been awarded £1.3 million funding by Wellcome to scale up in three NHS Trusts.

Person is shown holding a mobile phone with the SlowMo app open. Another person is shown walking past them. The top of the screen displays the text "Hi Angela, what are you thinking about?'. In the middle of the screen, a worry bubble is shown which has the text 'Someone is following me'. The bottom of the screen says 'What is you thought? Tap the bubble to enter your thought or swipe to see previous thoughts'

Optimising immunosuppression based on antibody testing does little to reduce kidney transplant failure rate

Treating patients who possess transplant rejecting antibodies, using best available combinations of oral drugs, does not have an impact on transplant failure...

Dialysis